Johnson & Johnson Invests Over $1 Billion to Strengthen U.S. Vision Manufacturing in Jacksonville, Fla.

NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ), a global healthcare company, has announced an investment of more than $1 billion in Jacksonville, Fla., to strengthen its vision operations by scaling the U.S.-based manufacturing, packaging and distribution capabilities. The investment includes construction of a new, state-of-the-art distribution facility, alongside advanced manufacturing and packaging technologies to expand capacity and meet growing demand for the company’s Acuvue-brand contact lenses, according to the announcement. Johnson & Johnson said it manufactures more than 1.7 billion Acuvue contact lenses annually for U.S. patients.